A Phase 2 Study of Nab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComa

Clinical trial NCT02494570 · COMPLETED

Trial details

NCT number: NCT02494570
Sponsor: Aadi Bioscience, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant PEComa

Start date: 2015-10-01
Primary completion: 2021-11-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.